chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Body aches; Fever; Headache; Nauseated; This is a spontaneous report from a contactable nurse, the patient. A 63-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 17Mar2021 at 10:30 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. Medical history included irregular heartbeat and gastroesophageal reflux disease (GERD). The patient had allergies to sulfa drugs (sulfonamide allergy). Concomitant medications included metoprolol (MANUFACTURER UNKNOWN) and omeprazole (MANUFACTURER UNKNOWN) all since an unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to COVID vaccine. The patient previously received ondansetron (ZOFRAN) from an unknown date for unknown indication and was allergic to it. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, patient was not tested for COVID-19. On 17Mar2021, within 3 hours, the patient was nauseated. By the midnight, on 18Mar2021 the patient had body aches, fever, headache and continued nausea. All symptoms except headache were resolved after 24 hours and the headache lasted for 2 days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events nauseated, body aches, fever were resolved on 19Mar2021 and headache was resolved on 20Mar2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
meningococcal B was given in error to 9mth old. Injection site swelling, and fatigue. Her pcp, but someone else is who called me to inform me of this, so they knows all about it. She was suppose to take the Hep B- 3rd dose, and was given the Meningitis Vaccine in error.
Localized cellulitis surrounding immunization sites 24 hours after Kinrix and Varivax.  Treated with supportive care and Cephalisin.
Information has been received from a physician who reported that one of his patient's mother mentioned that at some point last year, in 2009, a young woman was vaccinated with a dose of GARDASIL (lot # not reported) and the patient developed neurologic disorders. Unspecified medical attention was sought. The patient went through many tests and was currently in a wheelchair. At the time of this report, the patient's outcome was unknown. Neurologists did not believe that it was due to receiving GARDASIL. Neurologic disorder was considered to be disabling by the reporter. Attempts to verify the existence of an identifiable patient have been unsuccessful. No further information is available.
This spontaneous report as received from a nurse refers to a currently 5 years old male patient with multiple food allergies: peanut, tree nut, avocado, wheat. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23 (manufacturer unspecified, PNEUMOVAX could not be ruled out) (dose, lot number, expiration date were not reported). On an unknown date, the patient experienced unspecified reaction. The patient recovered from the reaction on an unspecified date. Relatedness between the event and vaccination with PNEUMOVAX 23 was not provided. Additional information is not expected.
Patient lied on the consent form that she is 16 which was signed by the father. It was later found found that the patient was 15 when the consent form was taken back to the store to reprocess. Patient was notified and second appointment has been cancelled.
Ramsay Hunt syndrome one year after vaccination.  Got blister in right ear, right side facial paralysis and hearing loss in the affected ear. Eye lid continues to droop.  Ramsay Hunt manifested from stress. It reactivates when I'm stressed in 2023 (tightening of face and eyelid droop). I don't believe I had singles before the vaccination because it would have activated due to my stressful lifestyle. Plus, I do not touch people in general much less people with a rash. I believe Shingrix gave me the shingles virus and if there is a law suite against them, I want to join it. Shingrix is using false advertising to say "You probably already have the shingles virus in you" as there are not tests to see if you do or not. It also cannot say truthfully that a percentage effective because how many people got the virus and did not report it?!  I believe they want to avoid a law suit of customers getting the virus from the vaccination like their predecessor so tell people these lies.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No information on patient's medical history, concurrent conditions and concomitant medications was provided. On 28-MAY-2017, the patient was vaccinated with an expired dose of GARDASIL 9) (lot # M014929, expiry date: 27-MAY-2017) (dose, route of administration not provided). No adverse event was reported. Additional information has been requested.
Fever with Chills - beginning at 2:30am on 4/19/2021 - Recorded temps below: 02:39 - 99.5 05:30 - 101.0 06:10 - 101.4 08:30 - 100.1 11:30 - 99.9 16:30 - 99.7 Recorded temps on 04/30/2021: 03:00 - 101.5 07:00 - 99.7 09:30 - 98.6 16:00 - 98.1  Other symptoms: -migraine headache -swelling in throat, hard to swallow  -dizzy/weak -muscle and joint pain -nausea -site swelling/pain/hardness:  very painful for 48 hours. felt like someone hit me with a baseball bat then stabbing me with a knife in the welt
This spontaneous report was received from a pharmacist and refers to a 72 year old female patient. The patient's pertinent medical history, drug reactions or allergies, and concomitant medications were not reported. On 02-MAY-2017, the patient was vaccinated with a properly-stored dose of PNEUMOVAX23 lot # M037669 with expiration date 09-MAY-2018 intramuscularly in the deltoid muscle (side was not specified) (dose was not reported) for prophylaxis. The pharmacist reported that the patient reported to him that on an unknown date in may 2017 (reported as "at an unspecified time after receiving the PNEUMOVAX23 vaccine") she experienced "pain, swelling, rash and redness" around the injection site (injection site pain, injection site swelling, injection site rash and injection site erythema). The patient also reported to the pharmacist that the portion of her arm around the injection site "increased in size" (local swelling). The pharmacist noted that the patient reported that she experienced "a fever of 101 °Fahrenheit (F) up to maximum of 101.6 °F for approximately 60 hours" (pyrexia). Additionally, the patient reported to the pharmacist that she "noticed pain in the arm where the vaccine injection was given, to the point where it was difficult to raised her arm", and that she experienced "decreased mobility in moving that arm where the injection was given because of soreness". At the time of reporting, the outcome of local swelling, injection site erythema, injection site swelling, injection site pain, injected limb mobility decreased and injection site rash were not reported. No product quality complain was reported. The causal relationship between the events and the suspect therapy PNEUMOVAX23 was not provided. Additional information is not expected as there is no consent to contact the reporter.
Initial report received from a health care professional on 10 September 2007. A 36-year-old patient (sex not reported) had received an injection of Tetanus toxoid Absorbed vaccine (route, site and lot number unknown), and within 24 hours, developed redness and swelling from their shoulder to the elbow of the vaccinated arm. No additional information was provided at the time of the report. A second case (2007-03101 - injection site redness, fever) was received from the same reporter. Follow-up information received from the reporter on 23 October 2007. The reporter did not have any further information.
A16-year-old received her first dose of vaccine; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A16-year-old received her first dose of vaccine) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A16-year-old received her first dose of vaccine). On 16-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A16-year-old received her first dose of vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A16-year-old received her first dose of vaccine) to be not applicable.    No concomitant medications were reported.   No treatment information was provided.
Woman got flu shot on 10/7/2017, called then pharmacy on 10/22/2017 complaining of arm/shoulder pain that has not gone away.
nose bleed - not a major gush, just when I blew my nose due to allergies/chronic runny nose, I saw blood in the tissue - lasted about 2 days
Pt not feverish not given APAP; sleeping-mom saw pt shaking 1/2 min; 15 mins later had big one-sz; pt taken to ER adm to hosp 5 days; BC, EEG, Spinal tap neg; 3rd day broke out in rash; dx febrile seizure due to roseola or & DTP; t102.8;
Shortness of breath, severe chest tightness started 5 to 8 minutes after the injection  lasted for 5 minutes  and were followed by an overwhelming  weakness, confusion, later also by abdominal cramps, some urinary urgency- all gradually improved over 30-40 minutes.  I felt later agitated, had dry mouth, headache- improved after drinking 8-10 cups of water.  I did not seek help. I stayed in the  shot area in a large tent.
Same day of vaccine about 8 hours later had stomach pain, severe nausea and vomiting. Unable to eat for 3 days with nausea and flu like symptoms(aches and pains al over body).  Had to go to ER after 3rd day where they treat me for nausea and re-hydrated with IV fluids. Three days after ER am still having mild nausea and have no energy.  Slow recuperation...
Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 04May2021 at 14:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included gliclazide (CLARITIN), acetylsalicylic acid (81MG ASPIRIN) and CENTRUM SILVER daily vitamins; all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 13Apr2021 at 16:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. On 05May2021 at 09:00, the patient experienced tinnitus. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
G1P0 28 y/o female, EDD 9/26/18, received Tdap vaccine on right deltoid on 7/6/18. Pt reports fever and malaise on 7/6/18 and 7/7/18 that was treated and resolved w/ TYLENOL. On 7/8/18 developed a hard area of redness below site of injection. Pt was seen on 7/9/18 for acute appt. On exam, pt had a 7x5 cm area of erythema and induration approx 5 cm below area of injection on right deltoid. Mild tenderness on palpation. Vitals were normal. No fetal distress reported.
5 days following the second dose, I began to notice two bald patches in my hair and a strange rash on my face and hands. I was diagnosed with alopecia areata and eczema, which I did not have prior.. Shortly after that, I started having intense pain and inflammation in my joints, mainly in my fingers, developed more pain and inflammation in my other joints, along with fatigue and muscle aches. I went to my PCP who diagnosed me with Raynaud?s Phenomenon and they are now referring me to a rheumatologist because my blood work indicates that I have lupus, which I also did not have prior.
Got very sick; This spontaneous case was reported by an other health care professional and describes the occurrence of ILLNESS (Got very sick) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Got very sick). At the time of the report, ILLNESS (Got very sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Is it too late to get a second shot after three months; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (Is it too late to get a second shot after three months) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Is it too late to get a second shot after three months). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (Is it too late to get a second shot after three months) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient received the first dose of vaccine three months ago and has been out of country since then.  Concomitant medications were not reported.  No treatment information was provided.
Woke up in night sweats, nausea, severe headache with neck and back pain. right shoulder pain and tingling right hand.
Initial report was received on 11 October 2011 from a consumer who is also the patient. A 59 year-old female patient with a history of leukemia and multiple allergies including seasonal, peach, mango and trout had received on 17 September 2011 at 4:35 PM FLUZONE (lot number, route and site of administration not reported) and later on the night of vaccination at 9 PM, the patient stated her "throat started to closed up" and her "arm was itchy." She stated that she still had it in the morning until noon on 18 September 2011. She reported that the injection site was "like a big hive" that was 3 1/2 inches long by 2 1/2 inches wide. The patient was evaluated by a physician. Treatments were not reported. Concomitant medications included GLEEVAC, KEPPRA, FLONASE and INTAL. No further information was available at the time of the report. The patient's outcome was recovered at noon on 18 September 2011. Documents held by sender: none.
Patient's right deltoid became red, inflamed, and hot about an hour after getting Pneumovax 23. Rash went from deltoid to Bicep & was hot.
Nausea then vomiting  for 24 hours. Also had general aches, headaches, chills, fatigue. The nausea and vomiting required call to  Dr or nausea medication prescription the next day..  Nausea and inability to eat much persisted  for more than a week and required visit to CNP for additional nausea medication.
Appendicitis; stomach pains; muscle aches; vomiting; constipation; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 09Dec2021 17:00 (Lot number: 32030BD) at the age of 31 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 2, Pfizer,  lot number=EW0158, on 27May2021 at 03:30PM, Left arm), administration date: 27May2021, when the patient was 30 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Pfizer on 06May2021 at 03:30PM, Right arm), administration date: 06May2021, when the patient was 30 years old, for COVID-19 Immunization. The following information was reported: APPENDICITIS (hospitalization, disability, medically significant) with onset 11Dec2021 04:00, outcome "recovering", described as "Appendicitis"; ABDOMINAL PAIN UPPER (hospitalization, disability) with onset 11Dec2021 04:00, outcome "recovering", described as "stomach pains"; MYALGIA (hospitalization, disability) with onset 11Dec2021 04:00, outcome "recovering", described as "muscle aches"; VOMITING (hospitalization, disability) with onset 11Dec2021 04:00, outcome "recovering", described as "vomiting"; CONSTIPATION (hospitalization, disability) with onset 11Dec2021 04:00, outcome "recovering", described as "constipation". The patient was hospitalized for appendicitis, abdominal pain upper, myalgia, vomiting, constipation (hospitalization duration: 1 day(s)). The events "appendicitis", "stomach pains", "muscle aches", "vomiting" and "constipation" were evaluated at the emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (11Dec2021) negative, notes: Nasal Swab. Therapeutic measures were taken as a result of appendicitis, abdominal pain upper, myalgia, vomiting, constipation and included treatment with Appendix Removal. Clinical course: Patient did not have covid prior vaccination.
The patient did not report he had a latex allergy on the immunization screening questionnaire. Was given single dose TD vaccine that contained latex. Reported to clinic today with red raised rash to arms, legs, back, chest and forehead.
Patient reported having significant redness and swelling at/around injection site and developing itchy skin on chest several hours after vaccine. She treated with BENADRYL before hives developed (none ever developed) and cold compress. Presented to pharmacy 1 week after vaccine with a bruise at injection site.
12 hours: swollen painful injection site, approx 1/4 inch raised, bright red, warm and hard to touch, about 2.5 inches in diameter, Day 2: same but now about 4 inches in diameter. Severe migraine (with related symptoms) lasting 24+ hours, muscle aches, queasy, spent day in bed, darkened bedroom, Day 3: injection site same, moderate to severe headache (not migraine) lasting 24 + hours, muscle aches, nausea, felt exhausted, spend day either in bed or in armchair in darkened bedroom, Day 4: injection site less swollen, still tender and warm, bright red. Mild headache, able to resume most activities except driving. Tired more easily than normal. Day 5: injection site improving, mild muscle aches only, mild headache. Fatigue. Day 6 to 8: Resume normal activities including driving with some mild aches and fatigue. Day 9 pretty much normal.
pt recv vax 13JUL98 & pt unresponsive to verbal/physical stimuli & skin pale & diaphoretic;parents stated lost consciousness when arrived home;pt brought back to clinic;ammonia salt broken under pt nose;BP 82/64,P84 became orientedx3;
Presented with fever, SOB, cough, diarrhea from MD office to ED; + Covid-19: admitted with Covid infection; TX with Maxipime, steroids, remdesivir, Singulair, zinc; developed Covid PNA; required high flow O2, tachycardia (card consult); HD initiated 9/6; 9/8 patient improving; weaning O2, last HD 9/7 and did not require at D/C.
Patient Fainted and fell over; blood pressure was taken and it had dropped to 78/50. Waited several minutes for patient to feel better since he did not feel like he needed emergency support. Later, it was taken and it went up 116/79.
Seizure disorder, being treated by neurologist at children's medical center. 2/15/06  Medical records reviewed. Diagnosis stated as myoclonic seizures. Additional symptoms at onset of AE include fever to 102 degrees, emesis, falling and hurting herself, quick startle movements, and twitching.  Per 60 day follow up report- Continues to have seizures and is on medication. Siezure disorder requiring medication. 12/31/09 Seizure disorder requiring medication.
Patient under age 18 was vaccinated with Moderna, which is a vaccine error, on 3/15/2021.  Troubleshooting: Scribe and vaccinator did not validate age;  screeners at the beginning of the process did not ask or turn her away on a Moderna-only day. An ID requirement has been put in place to prevent this situation from occurring in the future. Per supervising physician, this patient is able to receive the second dose of Moderna on an off-label, compassionate use basis.
7 days after the vaccination the injection site started to itch and a slight red circle appeared with a diameter of about 2 inches.  The red area was swollen and there was mild pain in addition to the itching.
Child came to office for vaccines. after pulling record from the state immunization registry it indicated that several vaccines were needed. spoke with mother about needed vaccines. I began with rotarix. After infant had taken the oral vaccine mother states that infant had been seen in the Pediatrics Clinic early today and given vaccines. These were not reflective in the report from the immunization registry. I placed a call to that office and spoke with staff who confirmed that the infant indeed received immunization at that office and she has not had time to get them documented into the immunization registry. I informed her that I also had administered a rotarix.  I informed mother that infant had received and 'extra' dose. I informed our clinics Medical Director, and the state Immunization Nurse for guidance for followup. Medical Director did see patient and Immunization Nurse from the state gave instructions and the possible side effects. This information was relayed to mother.
Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Lymph Node Swelling-Medium, Additional Details: Left side only, rash extends from neck to trunk and left  arm
Patient received the PCV-13 in error. Should have received PPSV23 instead. Had already received PCV-13 vaccine on 6/21/18.
Patient reports chest heaviness, muscle aches, loss of energy. No fever or chills noted.
Quite quickly, I started tasting metal in my mouth. It disappeared within a few hours. My left arm pain was insanely intense. It felt like someone had run over my arm with a car. It was so bad, but it went to just sore arm by the next day. Headache, fatigue, nausea and really flu-like symptoms lasted until 48 hours, then started to disappear.
Soreness at injection site, Headache,, chills, low-grade fever, aches, lethargic, tired.   It was the second dose.   The first dose in Oct 2020, had no side effects except soreness at injection site.